INCR Kewajiban utang agregat InterCure Ltd

InterCure Ltd. maintains a stable cash flow based on the demand for its pharmacy network and production. Its geographical footprint across Europe and Israel mitigates regional pricing risks. The overall debt position confirms financial stability, where 0.05 serves as the current parameter value. Experienced management is strengthening global partnerships by implementing high quality standards within the medical cannabis industry.

InterCure Ltd. - Utang perusahaan INCR (periode 04.07.2022 - 28.10.2026)

INCR (InterCure Ltd.): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Rega saham intercure.co|INCR - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Canndoc|INCR - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham InterCure|INCR - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku intercure.co|INCR - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi InterCure Ltd.|INCR - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang ekuitas intercure.co|INCR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Canndoc|INCR - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan InterCure

Analisis umum perusahaan:InterCure Ltd INCR

This indicator aggregates the total amount of all the issuer's liabilities, allowing for an assessment of the business's dependence on external capital and its solvency. The debt financing dynamics of InterCure Ltd. (INCR) reflect the company's operational margin of safety amid geopolitical turbulence in the Middle East and regulatory barriers when entering European medical cannabis markets.

Pesaing utama